Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Biotechnology

Health Care

Therapeutics

ExeVir

ExeVir's headquarters in Zwijnaarde, Belgium

Torsten Mummenbrauer

Caroline Sagaert

Viki Bockstal

Fiona Du Monceau

Erica Whittaker

Stef Heylen

Michel Kazatchkine

Caroline Thielen

Katja Rosenkranz

Jérôme Van Biervliet

Joël Henneghien

Advisory Board Team

Research and Development Team

Leadership Team

Finance and Operations Team

ExeVir

Org chart

Board & advisors

Teams

Advisory Board Team

Research and Development Team

Leadership Team

Finance and Operations Team

Offices

Similar companies